Optomed Oyj (OPTOMED.HE)
EUR 3.76
(1.48%)
EUR 3.76
(1.48%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -4.44 Million EUR | 18.84% |
| 2022 | -5.47 Million EUR | -28.78% |
| 2021 | -4.24 Million EUR | -33.74% |
| 2020 | -3.17 Million EUR | -10.5% |
| 2019 | -2.87 Million EUR | -126.74% |
| 2018 | -1.26 Million EUR | 56.08% |
| 2017 | -2.88 Million EUR | -4.68% |
| 2016 | -2.75 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -1.09 Million EUR | 28.76% |
| 2024 Q2 | -1.79 Million EUR | -64.5% |
| 2023 Q2 | -1.31 Million EUR | -13.57% |
| 2023 FY | -4.44 Million EUR | 18.84% |
| 2023 Q4 | -1.53 Million EUR | -248.52% |
| 2023 Q3 | -439 Thousand EUR | 66.59% |
| 2023 Q1 | -1.15 Million EUR | 17.18% |
| 2022 Q3 | -1.37 Million EUR | -3.69% |
| 2022 Q4 | -1.39 Million EUR | -1.45% |
| 2022 Q2 | -1.32 Million EUR | 3.07% |
| 2022 Q1 | -1.37 Million EUR | 29.24% |
| 2022 FY | -5.47 Million EUR | -28.78% |
| 2021 FY | -4.24 Million EUR | -33.74% |
| 2021 Q1 | -616 Thousand EUR | 5.52% |
| 2021 Q2 | -864 Thousand EUR | -40.26% |
| 2021 Q4 | -1.93 Million EUR | -132.41% |
| 2021 Q3 | -833 Thousand EUR | 3.59% |
| 2020 Q4 | -652 Thousand EUR | -58.25% |
| 2020 Q2 | -976 Thousand EUR | 21.92% |
| 2020 Q3 | -412 Thousand EUR | 57.79% |
| 2020 FY | -3.17 Million EUR | -10.5% |
| 2020 Q1 | -1.25 Million EUR | -2055.17% |
| 2019 Q3 | -1.25 Million EUR | -27.25% |
| 2019 FY | -2.87 Million EUR | -126.74% |
| 2019 Q4 | -58 Thousand EUR | 95.38% |
| 2019 Q1 | -575 Thousand EUR | -228.06% |
| 2019 Q2 | -987 Thousand EUR | -71.65% |
| 2018 Q3 | -476 Thousand EUR | 0.0% |
| 2018 Q4 | 449 Thousand EUR | 194.33% |
| 2018 FY | -1.26 Million EUR | 56.08% |
| 2017 FY | -2.88 Million EUR | -4.68% |
| 2016 FY | -2.75 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|